Nordea Investment Management
CRSP icon

Nordea Investment Management’s CRISPR Therapeutics CRSP Stock Holding History

Nordea Investment Management’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-131,300
Closed -$8.39M – 866
2025
Q3 		$8.39M Buy
131,300
+3,800
+3% +$218K 0.01% 482
2025
Q2 		$6.25M Buy
127,500
+900
+0.7% +$34.8K 0.01% 522
2025
Q1 		$4.31M Buy
126,600
+1,200
+1% +$50.9K ﹤0.01% 565
2024
Q4 		$4.91M Buy
125,400
+5,300
+4% +$250K 0.01% 540
2024
Q3 		$5.66M Sell
120,100
-6,800
-5% -$345K 0.01% 508
2024
Q2 		$6.9M Sell
126,900
-21,800
-15% -$1.26M 0.01% 467
2024
Q1 		$10.3M Buy
148,700
+43,100
+41% +$3.09M 0.01% 418
2023
Q4 		$6.68M Sell
105,600
-2,500
-2% -$138K 0.01% 476
2023
Q3 		$5.04M Buy
108,100
+12,800
+13% +$661K 0.01% 501
2023
Q2 		$5.49M Sell
95,300
-5,900
-6% -$335K 0.01% 501
2023
Q1 		$4.55M Sell
101,200
-800
-0.8% -$38.9K 0.01% 536
2022
Q4 		$4.05M Buy
102,000
+14,100
+16% +$748K 0.01% 559
2022
Q3 		$5.79M Sell
87,900
-800
-0.9% -$58K 0.01% 480
2022
Q2 		$5.39M Sell
88,700
-8,300
-9% -$488K 0.01% 515
2022
Q1 		$6.27M Buy
97,000
+2,900
+3% +$182K 0.01% 543
2021
Q4 		$7.55M Buy
94,100
+18,500
+24% +$1.62M 0.01% 486
2021
Q3 		$8.5M Buy
+75,600
New +$9.49M 0.01% 446

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GP
GSK plc London $602M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nordea Investment Management's CRSP Position: Q4 2025 in Review

Nordea Investment Management sold out of CRISPR Therapeutics (CRSP) in Q4 2025, closing a stake of 131,300 shares — an estimated $8.39M sold.

Nordea Investment Management first reported a position in CRSP in Q3 2021 and held it in 17 quarters. The position peaked at $10.3M in Q1 2024. 480 funds tracked by Wall St. Rank hold CRSP as of Q4 2025.

  • Nordea Investment Management reported no remaining CRISPR Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Nordea Investment Management sold 131,300 CRISPR Therapeutics shares in Q4 2025, an estimated $8.39M.
  • Nordea Investment Management first reported a position in CRISPR Therapeutics in Q3 2021 and held it in 17 quarters.
  • Nordea Investment Management's CRISPR Therapeutics position peaked at $10.3M in Q1 2024.
  • 480 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2025.

Based on Nordea Investment Management's 13F filing for Q4 2025, filed 8 Jan 2026.